CLINICAL_TRIALS
trial_result
· 2019-05-29
Clinical Trial Update: TRial on the Endocrine Activity of Neoadjuvant Degarelix [Phase 2]
Summary
Phase 2 trial evaluating the endocrine activity of neoadjuvant degarelix in invasive breast cancer has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer Invasive Nos | Phase 2 | Status: COMPLETED | Results posted: 2019-05-29